StageZero Life Sciences Ltd Cash Flow Reinvestment Rate
Latest as of September 2023:
0.00x
StageZero Life Sciences Ltd cash flow reinvestment rate. StageZero Life Sciences Ltd (SZLS) has a Cash Flow Reinvestment Rate of 0.00x as of September 2023, reinvesting CA$0.00 (capex CA$0.00 ) from operating cash flow of CA$47.82K. Explore StageZero Life Sciences Ltd cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
0.00x
(Capex + Investments) / Operating CF
Total Reinvested
CA$0.00
Capex + Investments
Operating Cash Flow
CA$47.82K
CAD
Capital Expenditures
CA$0.00
CAD
StageZero Life Sciences Ltd Cash Flow Reinvestment Rate by Year (None–None)
StageZero Life Sciences Ltd cash flow reinvestment rate by year from None to None. Year-by-year capital reinvestment analysis for StageZero Life Sciences Ltd. For the full cash flow conversion analysis, see StageZero Life Sciences Ltd operating cash flow efficiency.
| Year | Reinvestment Rate | Total Reinvested (CAD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow